top of page

CYNAERA

About Us
Case Studies
- CYNAERA Framework
- Clinical Trial Simulator
Institute
Invisible Trigger Webinar
- The Eve Research Project
- Sponsor Eve Research Project
Marketplace
Publications
- AVERY
- DAWN
More

Use tab to navigate through the menu items.

The Human Variable

All Posts
AI in Healthcare
Flare Management Insights
Business Insights
Chronic Illness Innovations
Health and Recovery Strategies
Philanthropic Tools
AI Strategy
Public Infrastructure
Data Ethics
Public Policy
White Paper
Healthcare Innovations
CRISPR
Relational Intelligence
Social Impact

Search

The Hidden Prevalence of Lupus in the U.S.

The Hidden Prevalence of Lupus in the U.S.

The Hidden Prevalence of Lupus in the U.S.

Remission Pathways in Chronic Lyme: Chronicity Drivers, Drug Combinations, and Remission Standards

Remission Pathways in Chronic Lyme: Chronicity Drivers, Drug Combinations, and Remission Standards

Remission Pathways in Chronic Lyme: Chronicity Drivers, Drug Combinations, and Remission Standards

Biological Adaptive Reduction State™ (BARS™): A Chronic Illness Threshold Model

Biological Adaptive Reduction State™ (BARS™): A Chronic Illness Threshold Model

Biological Adaptive Reduction State™ (BARS™): A Chronic Illness Threshold Model

Tinnitus in Long COVID: Phenotype Classification and Combination Therapy

Tinnitus in Long COVID: Phenotype Classification and Combination Therapy

Tinnitus in Long COVID: Phenotype Classification and Combination Therapy

Best Practices for Lupus Clinical Trials

Best Practices for Lupus Clinical Trials

Best Practices for Lupus Clinical Trials

CRISPR Cas9 Immunity and Gene Editing Immune Rejection: Why Preexisting Immunity to Cas9 Requires State-Dependent Deployment

CRISPR Cas9 Immunity and Gene Editing Immune Rejection: Why Preexisting Immunity to Cas9 Requires State-Dependent Deployment

CRISPR Cas9 Immunity and Gene Editing Immune Rejection: Why Preexisting Immunity to Cas9 Requires State-Dependent Deployment

CYNAERA

Institute
Case Studies
DAWN
Marketplace
Contact

Subscribe to our newsletter • Don’t miss out!

Email*

I want to subscribe to your mailing list.

Core CYNAERA Libraries

MECFS Library
Lyme Library
Autoimmune Library
Long COVID Library
CRISPR Remission Library

Bioadaptive Systems Therapeutics™ (BST) and affiliated frameworks are proprietary systems developed by Cynthia Adinig and licensed exclusively to CYNAERA™ for commercialization, research integration, and platform development. U.S. Provisional Patent Application No. 63/909,951. Patent pending. All rights reserved. CYNAERA is a Virginia-based LLC registered in Montana, USA.

bottom of page